pharma · Hepatitis B, Chronic · Cancer
EmeraMed
Immunocore Ireland Limited
EmeraMed clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Ranelagh, IE
- Founded
- 2007
- Employees
- 7
- Programs
- 5
- Drugs
- 9
- Patents
- 0
EmeraMed projects
5 ClinicalTrials.gov programs sponsored by EmeraMed.
EmeraMed has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
IMC-M113V
Immunocore Ireland Limited
Chronic HIV infection
1 trial -
IMC-R117C
Immunocore Ireland Limited
Cancer
1 trial -
IMCgp100-202
Immunocore Ireland Limited
Previously untreated advanced uveal melanoma (UM)
1 trial -
IMC-I109V Single Ascending Dose
Immunocore Ireland Limited
Hepatitis B, Chronic
1 trial -
Phase 1 Study of IMC-P115C in Advanced PRAME Positive Cancers
Immunocore Ireland Limited
Advanced PRAME Positive Cancers
1 trial
Frequently asked questions
How many clinical projects does EmeraMed have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.